Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
US-2024409487-A1 · Dec 12, 2024 · US
US11807602B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11807602-B2 |
| Application number | US-202117543877-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 7, 2021 |
| Priority date | Dec 10, 2020 |
| Publication date | Nov 7, 2023 |
| Grant date | Nov 7, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a process for preparing a 3-isopropenyl-6-heptenal compound of the following formula (2): wherein R 1 represents a hydrogen atom or a methyl group, the process comprising: subjecting a 3-isopropenyl-6-heptenoate ester compound of the following formula (1): wherein R 1 is as defined above, and R 2 represents a monovalent hydrocarbon group having 1 to 10 carbon atoms, to a reduction reaction with a reducing agent to form the 3-isopropenyl-6-heptenal compound (2).
Opening claim text (preview).
The invention claimed is: 1. A process for preparing a 3-isopropenyl-6-heptenal compound of the following formula (2): wherein R 1 represents a hydrogen atom or a methyl group, the process comprising: subjecting a 3-isopropenyl-6-heptenoate ester compound of the following formula (1): wherein R 1 is as defined above, and R 2 represents a monovalent hydrocarbon group having 1 to 10 carbon atoms, to a reduction reaction with a reducing agent to form the 3-isopropenyl-6-heptenal compound (2), wherein the reducing agent is selected from a group consisting of a complex hydride, an alkoxy derivative of the complex hydride, and an alkyl derivative of the complex hydride. 2. A process for preparing a 6-isopropenyl-3-methyl-3,9-decadienyl carboxylate compound of the following formula (4): wherein R 1 represents a hydrogen atom or a methyl group, and R 3 represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms, the process comprising: the process for preparing the 3-isopropenyl-6-heptenal compound (2) according to claim 1 ; subjecting the 3-isopropenyl-6-heptenal compound (2) thus obtained to a four-carbon homologation reaction including a Wittig reaction, using an ethyltriphenylphosphonium halide compound and ethylene oxide to form a 6-isopropenyl-3-methyl-3,9-decadienol compound of the following formula (3): wherein R 1 is as defined above; and subjecting the 6-isopropenyl-3-methyl-3,9-decadienol compound (3) thus obtained to an esterification reaction to form the 6-isopropenyl-3-methyl-3,9-decadienyl carboxylate compound (4). 3. The process for preparing the 3-isopropenyl-6-heptenal compound (2) according to claim 1 , the process further comprising: subjecting a 4-pentenyltriphenylphosphonium halide compound of the following formula (5): wherein R 1 is as defined above, Ph represents a phenyl group, and X represents a halogen atom, to a Wittig reaction with a 2-propanone compound of the following formula (6) having a protected hydroxyl group: wherein R 4 represents a protective group for a hydroxyl group, to form a 2-methyl-2,6-heptadiene compound of the following formula (7) having a protected hydroxyl group at position 1: wherein R 1 and R 4 are as defined above; removing the protective group from the 2-methyl-2,6-heptadiene compound (7) having a protected hydroxyl group at position 1 to form a 2-methyl-2,6-heptadienol compound of the following formula (8): wherein R 1 is as defined above; and subjecting the 2-methyl-2,6-heptadienol compound (8) thus obtained to a Johnson-Claisen rearrangement with an orthoacetate ester compound to form the 3-isopropenyl-6-heptenoate ester compound (1). 4. The process for preparing the 3-isopropenyl-6-heptenal compound (2) according to claim 1 , the process further comprising: subjecting a 4-pentenyltriphenylphosphonium halide compound of the following formula (5): wherein R 1 represents a hydrogen atom or a methyl group, Ph represents a phenyl group, and X represents a halogen atom, to a Wittig reaction with a 2-propanone compound of the following formula (6) having a protected hydroxyl group: wherein R 4 represents a protective group for a hydroxyl group, followed by removal of the protective group to form a 2-methyl-2,6-heptadienol compound of the following formula (8): wherein R 1 is as defined above; and subjecting the 2-methyl-2,6-heptadienol compound (8) thus obtained to a Johnson-Claisen rearrangement with an orthoacetate ester compound to form the 3-isopropenyl-6-heptenoate ester compound (1). 5. The process for preparing the 6-isopropenyl-3-methyl-3,9-decadienyl carboxylate compound (4) according to claim 2 , the process further comprising: subjecting a 4-pentenyltriphenylphosphonium halide compound of the following formula (5): wherein R 1 represents a hydrogen atom or a methyl group, Ph represents a phenyl group, and X represents a halogen atom, to a Wittig reaction with a 2-propanone compound of the following formula (6) having a protected hydroxyl group: wherein R 4 represents a protective group for a hydroxyl group, to form a 2-methyl-2,6-heptadiene compound of the following formula (7) having a protected hydroxyl group at position 1: wherein R 1 and R 4 are as defined above; removing the protective group from the 2-methyl-2,6-heptadiene compound (7) having a protected hydroxyl group at position 1 to form a 2-methyl-2,6-heptadienol compound of the following formula (8): wherein R 1 is as defined above; subjecting the 2-methyl-2,6-heptadienol compound (8) thus obtained to a Johnson-Claisen rearrangement with an orthoacetate ester compound to form the 3-isopropenyl-6-heptenoate ester compound (1). 6. The process for preparing a 6-isopropenyl-3-methyl-3,9-decadienyl carboxylate compound (4) according to claim 2 , the process further comprising: subjecting a 4-pentenyltriphenylphosphonium halide compound of the following formula (5): wherein R 1 represents a hydrogen atom or a methyl group, Ph represents a phenyl group, and X represents a halogen atom, to a Wittig reaction with a 2-propanone compound of the following formula (6) having a protected hydroxyl group: wherein R 4 represents a protective group for a hydroxyl group, followed by removal of the protective group to form a 2-methyl-2,6-heptadienol compound of the following formula (8): wherein R 1 is as defined above; and subjecting the 2-methyl-2,6-heptadienol compound (8) thus obtained to a Johnson-Claisen rearrangement with an orthoacetate ester compound to form the 3-isopropenyl-6-heptenoate ester compound (1). 7. A process for preparing a 3-isopropenyl-6-heptenoate ester compound of the following formula (1):
Monocarboxylic acid esters having at least two carbon-to-carbon double bonds · CPC title
by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof · CPC title
by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds · CPC title
from ortho-esters · CPC title
by splitting of carbon-to-carbon bonds and redistribution, e.g. disproportionation or migration of [IMAGE cpc-sch-C07C-0963.gif] groups between different molecules · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.